AAAAAA
Results:
1-16
|
Results: 16
Authors:
PETITT RM
Citation: Rm. Petitt, PRECIPITOUS FALL IN PLATELET COUNT WITH ANAGRELIDE - CASE-REPORT AND CRITIQUE OF DOSING RECOMMENDATIONS - A COMMENT, Pharmacotherapy, 18(3), 1998, pp. 659-659
Authors:
BEST PJM
PETITT RM
Citation: Pjm. Best et Rm. Petitt, MULTIPLE SKIN CANCERS ASSOCIATED WITH HYDROXYUREA THERAPY, Mayo Clinic proceedings, 73(10), 1998, pp. 961-963
Authors:
PETRONE ME
TIERNEY DS
MAHONEY MP
PETITT RM
SILVERSTEIN MN
Citation: Me. Petrone et al., ANAGRELIDE FOR TREATMENT OF HIGH PLATELET COUNT IN PATIENTS WITH POLYCYTHEMIA-VERA, British Journal of Haematology, 102(1), 1998, pp. 308-308
Authors:
BEST PJ
PETITT RM
PITTELKOW MR
Citation: Pj. Best et al., HYDROXYUREA-ASSOCIATED LEG ULCERATION - IN RESPONSE, Annals of internal medicine, 129(3), 1998, pp. 252-253
Authors:
BEST PJ
DAOUD MS
PITTELKOW MR
PETITT RM
Citation: Pj. Best et al., HYDROXYUREA-INDUCED LEG ULCERATION IN 14 PATIENTS, Annals of internal medicine, 128(1), 1998, pp. 29-32
Authors:
PETITT RM
SILVERSTEIN MN
PETRONE ME
Citation: Rm. Petitt et al., ANAGRELIDE FOR CONTROL OF THROMBOCYTHEMIA IN POLYCYTHEMIA AND OTHER MYELOPROLIFERATIVE DISORDERS, Seminars in hematology, 34(1), 1997, pp. 51-54
Authors:
SOLBERG LA
TEFFERI A
OLES KJ
TARACH JS
PETITT RM
FORSTROM LA
SILVERSTEIN MN
Citation: La. Solberg et al., THE EFFECTS OF ANAGRELIDE ON HUMAN MEGAKARYOCYTOPOIESIS, British Journal of Haematology, 99(1), 1997, pp. 174-180
Authors:
FAIRBANKS VF
KLEE GG
WISEMAN GA
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., MEASUREMENT OF BLOOD-VOLUME AND RED-CELL MASS - REEXAMINATION OF CR-51 AND I-125 METHODS (CORRECTED VERSION OF VC666), Blood cells, molecules, & diseases, 22(15), 1996, pp. 169-186
Authors:
FAIRBANKS VF
KLEE GG
WISEMAN GA
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., MEASUREMENT OF BLOOD-VOLUME AND RED-CELL MASS - REEXAMINATION OF CR-51 AND I-125 METHODS, Blood cells, molecules, & diseases, 22(15), 1996, pp. 169-186
Authors:
SILVERSTEIN MN
PETRONE ME
PETITT RM
DEMENT MP
VUKOVICH RA
Citation: Mn. Silverstein et al., THE SAFETY PROFILE OF ANAGRELIDE FOR TREATMENT OF THROMBOCYTHEMIA, Blood, 88(10), 1996, pp. 2321-2321
Authors:
SILVERSTEIN MN
TEFFERI A
LI CY
PETITT RM
Citation: Mn. Silverstein et al., A PILOT-STUDY OF ANAGRELIDE FOR THE TREATMENT OF MYELOFIBROSIS WITH MYELOID METAPLASIA (MMM), Blood, 86(10), 1995, pp. 3195-3195
Authors:
BERESSI AH
TEFFERI A
SILVERSTEIN MN
PETITT RM
HOAGLAND HC
Citation: Ah. Beressi et al., OUTCOME ANALYSIS OF 34 PREGNANCIES IN WOMEN WITH ESSENTIAL THROMBOCYTHEMIA, Archives of internal medicine, 155(11), 1995, pp. 1217-1222
Authors:
PETRONE ME
SILVERSTEIN MN
WILSON J
PETITT RM
DEMENT MP
DEVINE CL
BISCARDI CA
HU WL
Citation: Me. Petrone et al., EFFECTS OF ANAGRELIDE HCI ON BLEEDING-TIME AND COAGULATION TESTS, Blood, 84(10), 1994, pp. 10000058-10000058
Authors:
BERESSI AH
TEFFERI A
SILVERSTEIN MN
PETITT RM
HOAGLAND HC
Citation: Ah. Beressi et al., OUTCOME ANALYSIS OF 36 PREGNANCIES IN ESSENTIAL THROMBOCYTHEMIA, Blood, 82(10), 1993, pp. 10000383-10000383
Authors:
FAIRBANKS VF
HOYER JD
TEFFERI A
PETITT RM
SILVERSTEIN MN
Citation: Vf. Fairbanks et al., REQUIEM FOR THE CR-51 RED-CELL MASS - COST AND OUTCOME CONSIDERATIONS, Blood, 82(10), 1993, pp. 10000552-10000552
Authors:
PRUTHI RK
TEFFERI A
PETITT RM
Citation: Rk. Pruthi et al., REVERSIBLE MARKED SPLENOMEGALY IN PERNICIOUS-ANEMIA, Annals of internal medicine, 119(10), 1993, pp. 1053-1053
Risultati:
1-16
|